PCOS Has Been Renamed. Here Is Why It Matters.

On 12 May 2026, a landmark paper published in The Lancet officially renamed polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome. The old name was built on a surgical observation from a century ago that was misleading, stigmatising, and obscured the true nature of the condition. The new name puts insulin resistance and metabolic dysfunction where they have always belonged: at the centre.

Perimenopause, Oestrogen and Blood Sugar: The Connection Most Women Miss

As oestrogen declines during perimenopause, insulin sensitivity decreases in parallel. The same meal that your body handled easily at 38 can produce a larger blood sugar spike and require more insulin to clear at 47. This is not a failure of willpower. It is a measurable hormonal change with a measurable metabolic consequence.